Data / Form D filings / Magellan Bioscience Group Inc
Magellan Bioscience Group Inc: Form D filing
Magellan Bioscience Group Inc, a biotechnology company in Tampa, FL, filed a Form D with the SEC in 2012. The latest, on September 17, 2012, reports $25,000 sold of a $100,000 offering to 2 investors.
Find out what Magellan Bioscience Group Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4519 GEORGE ROAD, SUITE 120, Tampa, FL, 33634
- Phone
- (813) 884-3131
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 505, Rule 506
- SEC identifier (CIK)
- 1558050
The full lists. Form D filings in Florida: 2,702 rows, $107.02, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 17, 2012 | New notice | $100,000 | $25,000 | $75,000 | 2 | Sep 5, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Michael Cronan | Executive Officer | |
| James Carr Gamble III | Director | |
| Christopher Carr Mallavarapu | Director |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Sep 17, 2012 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Magellan Bioscience Group Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.